Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:1261 (29 November), doi:10.1136/bmj.327.7426.1261
Gabriel C Oniscu, specialist registrar1, Annemarie A H Schalkwijk, research assistant2, Rachel J Johnson, principal statistician3, Helen Brown, senior statistician4, John L R Forsythe, consultant surgeon1
1 Transplant Unit, New Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, 2 Scottish Renal Registry, Glasgow Royal Infirmary, Glasgow G4 0SF, 3 United Kingdom Transplant, Stoke Gifford, Bristol BS34 8RR, 4 Information and Statistics Division, Scottish National Health Service, Edinburgh EH5 3SQ
Correspondence to: J L R Forsythe john.forsythe{at}luht.scot.nhs.uk
Design Cohort study.
Setting Renal and transplant units in Scotland.
Participants 4523 adults starting renal replacement therapy in Scotland between 1 January 1989 and 31 December 1999.
Main outcome measures Impact of age, sex, social deprivation, primary renal disease, renal or transplant unit, and geography on access to the waiting list and renal transplantation.
Results 1736 of 4523 (38.4%) patients were placed on the waiting list for renal transplantation and 1095 (24.2%) underwent transplantation up to 31 December 2000, the end of the study period. Patients were less likely to be placed on the list if they were female, older, had diabetes, were in a high deprivation category, and were treated in a renal unit in a hospital with no transplant unit. Patients living furthest away from the transplant centre were listed more quickly. The only factors governing access to transplantation once on the list were age, primary renal disease, and year of listing. A significant centre effect was found in access to the waiting list and renal transplantation.
Conclusions A major disparity exists in access to the renal transplant waiting list and renal transplantation in Scotland. Comorbidity may be an important factor.
The Renal Association has highlighted the importance of ensuring there is equity of access to transplantation.5 However, growing evidence, mainly from the United States, shows that transplantation rates are associated with a patient's health status as well as socioeconomic and geographical factors, and that these vary significantly across different ages and races and between men and women.6-9 We investigated the relation between socioeconomic and geographical factors and access to the renal transplant waiting list and renal transplantation in Scotland to determine whether similar discrepancies exist.
The clinical outcomes were access to the waiting list for transplantation and access to a kidney graft. Regression analysis was used to investigate the factors associated with the likelihood of being placed on the waiting list and undergoing transplantation. We determined the time when 50% of the patients were placed on the waiting list or underwent transplantation.
Variables considered were patient's age when starting renal replacement therapy, sex, social deprivation, distance from the patient's home to the transplant centre, primary renal disease, type and year of first renal replacement therapy, centre where first renal replacement therapy was undertaken, and the centre where the patient was listed for transplantation.
An intention to treat approach was used to calculate the time it took 50% of the patients to be listed. This method, although statistically correct, does not give a true indicator of how long it takes for someone suitable for transplantation to be put on the list. Therefore as an indicator of current clinical practice, we performed a separate analysis, taking into account only patients put on the list within the study period. See bmj.com for details of statistics.
Access to the waiting list
Sex and age
The table shows the relative risk of access to the renal transplant waiting list for the variables analysed in the intention to treat analysis. The same variables were used in the analysis of the access time to the waiting list (see bmj.com). Women were less likely to be put on the list and had to wait significantly longer before they were. The older the patient, the lower the rate of being placed on the list and the longer the time spent on dialysis before being put on the list.
Social deprivation, primary renal disease, and type of first renal replacement therapy
The likelihood of placement on the waiting list decreased with increased social deprivation. Patients with diabetic nephropathy had the lowest rate for being put on the list, with less than 50% being put on it within 10 years of starting dialysis. Patients with diabetes who were eventually listed, however, spent the shortest time on dialysis before being put on the list. Patients who underwent peritoneal dialysis were placed on the list more quickly and had a 46% better chance of listing than those on haemodialysis.
Renal unit and transplant centre
Patients were more likely to be listed and waited a shorter time if referred to centres 1 and 2 (see table). Patients starting dialysis in the four units situated in a hospital with a transplant centre were more likely to be placed on the list and waited a significantly shorter time than the other patients.
|
Distance to transplant centre
Patients living furthest away from the transplant centre (> 100 km) were more likely to be put on the waiting list, and this was sooner after starting dialysis than patients living closer to the unit. We found a 5% reduction in the rates of listing for each year closer to the end of the follow up period. When the analysis was restricted to those patients who were put on the list (rather than the intention to treat analysis), all variables except sex remained important factors for access to the list.
Access to transplantation
Older patients were less likely to undergo transplantation and spent longer on the waiting list (see bmj.com). Patients with renal failure of unknown origin and those with multisystemic disease had the least chance of undergoing transplantation. They also spent over two years on the active waiting list before receiving a transplant.
We found a significant centre effect on the likelihood of transplantation and time spent on the waiting list. This seemed to be due to the outlying effect of centre 2, where patients had a 43% less chance of undergoing transplantation than those in centre 1. The chance of transplantation decreased by 4% for each year closer to the end of the study period.
Age is a major factor influencing access to transplantation. The sharper decline in access to the waiting list indicates that the main selection process takes place at this stage and may be attributable to higher comorbidity in older people. Once on the waiting list, the difference is diminished.
Explanations for the observed sex difference include patient preference, sex selection by health professionals, socioeconomic and health status, non-compliance, and sex based differences in family preferences for transplantation.12-14 Once on the waiting list, women have a similar probability to men of receiving a transplant, suggesting that the system for allocation in the United Kingdom may have eliminated differences between the sexes, unlike other transplant programmes, where there is a persistent disparity.10 15
The rates for placement on the waiting list declined with increasing socioeconomic deprivation. Patients who are socioeconomically disadvantaged may have higher comorbidity, and medical non-compliance may be more common.16 It is also possible that healthcare workers are biased to manage patients in ways that allow some to be listed sooner than others.17 Unlike other analyses, our study shows that once on the list, patients have an equal chance of transplantation, irrespective of socioeconomic status.6
Patients with diabetes have the lowest rate of access to the waiting list for transplantation, which may be due to additional and more severe comorbidity. Although transplantation rates for these patients are better than their listing rates, the likelihood of further complications may underlie the persisting differences in access to transplantation.
|
The type of first renal replacement therapy also predicted access to the waiting list. This finding should be interpreted with care, as the type of first dialysis varies, and many patients will switch between dialysis modalities throughout their treatment. A longer waiting time on dialysis before transplantation has been correlated with a poorer outcome.18 We found no correlation between the chance of transplantation and the length of time spent on dialysis before listing.
The further away from the transplant centre patients lived the quicker they were placed on the waiting list. No differences were found in access to transplantation after being put on the list.
Patients had a better chance of being placed on the waiting list when they started dialysis in a renal unit in a hospital with a transplant unit. Factors implicated are centre characteristics, size, and organisational aspects, the attitudes of healthcare staff towards transplantation, and training.4 13 This effect may be eliminated with the introduction of guidelines for evaluating candidates for transplantation, as used in the United States and Europe.16 19
Conclusions
Inequities in access to the renal transplant waiting list and renal transplantation are apparent in Scotland. Throughout the United Kingdom the management of end stage renal failure, referral patterns for transplantation, and the transplantation process are similar, therefore these inequities may exist elsewhere.
This is an abridged version; the full version is on bmj.com Contributors: See bmj.com
Funding: GCO was funded by a grant from the Scottish Executive. The guarantor accepts full responsibility for the conduct of the study, had access to the data, and controlled the decision to publish.
Competing interests: JLRF has received both honorariums from Fujisawa, Novartis, Roche, and Wyeth for speaking at meetings or serving on advisory groups and funding for attending meetings. These companies have also supported some research by the department's research group.
Ethical approval: This study was part of a research project that was approved by the Lothian research ethics committee (research ethics subcommittee for medical and clinical oncology; reference No LREC/2000/4/163).
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses